News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Longcor Jarrod
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/18/2023 |
4
| Longcor Jarrod (COO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 144,000 options to buy
@ $1.68, valued at
$241.9k
|
|
| 01/27/2022 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 475,000 options to buy
@ $0.55, valued at
$261.3k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Bought 29,630 shares
@ $1.35, valued at
$40k
|
|
| 06/08/2020 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Bought 65,218 shares
@ $1.145, valued at
$74.7k
Bought 32,609 options to buy
@ $1.2075, valued at
$39.4k
|
|
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.99, valued at
$59.7k
|
|
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2018 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Bought 500 shares
@ $2.71, valued at
$1.4k
|
|
| 03/14/2018 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Sold 13,000 shares
@ $1.1844, valued at
$15.4k
|
|
| 09/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/12/2016 |
4
| Longcor Jarrod (Sr. VP of Corp Dev & Ops) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.93, valued at
$219.8k
|
|
|
|